Medilink

Developer of antibody-drug conjugates for cancer treatment

placeSuzhou, Jiangsu, China calendar_todayFounded 2020 groups49 employees language medilinkthera.com

Registered entities

Social engagement

Social engagement: 2.7K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include LYFE Capital, Qiming Venture Partners, Loayal Valley Capital, Apricot Capital.

Investor typeCountShare
Venture capital583%
Private equity117%

Recent activity

15 May 2026
Event
ASCO 2026
Coming soon